This is a resubmission of a competitive renewal application of the Collaborative Study of Ovarian Cancer (R01- CA58598), a population-based case-control study in its second funding cycle. In this application, we follow-up on several leads from our data to examine a novel role for the vitamin D endocrine / signaling pathway in the etiology of ovarian cancer associated with proteolytic degradation of the ovulatory follicle, as well as post- ovulatory tissue remodeling that accompany healing and repair of the traumatized ovarian tissue. In addition to the genes involved with vitamin D metabolism, we have included key signaling pathways targeted by vitamin D and its receptor complex that influence the dynamic equilibrium between the extracellular matrix and ovarian epithelial cells during the wounding and repair associated with ovulation. The ovarian surface epithelium is subject to repeated wounding and healing during ovulation. It is thought that this repeated proliferative stimulation may be a key pathway to the malignant transformation of ovarian epithelial cells. The study methodology is based on a three-stage design within the Ovarian Cancer Association Consortium in which we will examine genetic variation in the vitamin D endocrine / signaling pathway that might influence the risk of ovarian cancer.
Aim 1 will include a two-stage analysis of 2,930 cases and frequency-matched controls, identified in Hawaii and six other geographic areas, to identify common variants among ~3000 tagSNPs in genes that may be related to the malignant transformation of the ovary.
In Aim 2 (Stage 3), we will conduct a validation study of a reduced set of ~62 (~2%) of the most promising SNPs from Aim 1 among 5,236 OvCa cases and frequency-matched controls in an independent set of six case-control studies. As part of our analysis, we will examine gene-environment and gene-gene interactions. This study fulfills key missions of the NCI's Epidemiology and Genetics Research Program by potentially providing new insights into the biology of ovarian malignancy and into the complex interactions of host genetics with environment and lifestyle in the carcinogenic process. The identification of ovarian cancer susceptibility genes that are related to ovarian surface epithelium tissue remodeling might shed light on novel vitamin D-associated enzymatic pathways in this malignancy.

Public Health Relevance

Although ovarian cancer only accounts for 3% of new malignancies among women in the U.S., it is the fifth most common cause of cancer mortality and is the cause of 6% of all cancer deaths. There is an urgent need to establish a panel of genetic variants associated with ovarian cancer susceptibility that can be used in combination with known epidemiological risk factors to identify higher-risk women. The identification of ovarian cancer susceptibility genes that are related to OSE wounding and post-ovulatory tissue remodeling might shed light on important vitamin D-associated pathways in the carcinogenic process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058598-14
Application #
8271264
Study Section
Epidemiology of Cancer Study Section (EPIC)
Program Officer
Mahabir, Somdat
Project Start
1993-08-15
Project End
2012-11-01
Budget Start
2012-06-01
Budget End
2012-11-01
Support Year
14
Fiscal Year
2012
Total Cost
$180,192
Indirect Cost
$43,263
Name
University of Hawaii
Department
Type
Organized Research Units
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Earp, Madalene; Winham, Stacey J; Larson, Nicholas et al. (2016) A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget 7:7381-9
(2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 53:800-811
Lee, Alice W; Templeman, Claire; Stram, Douglas A et al. (2016) Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril 105:35-43.e1-10
Clyde, Merlise A; Palmieri Weber, Rachel; Iversen, Edwin S et al. (2016) Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. Am J Epidemiol 184:579-589
Cannioto, Rikki; LaMonte, Michael J; Risch, Harvey A et al. (2016) Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 25:1114-24
(2016) Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nat Commun 7:12675
Permuth, Jennifer B; Pirie, Ailith; Ann Chen, Y et al. (2016) Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Hum Mol Genet 25:3600-3612
(2016) No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol 141:386-401
Lee, Alice W; Ness, Roberta B; Roman, Lynda D et al. (2016) Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol 127:828-36
Cuellar-Partida, Gabriel; Lu, Yi; Dixon, Suzanne C et al. (2016) Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Hum Genet 135:741-56

Showing the most recent 10 out of 106 publications